Spark Therapeutics
Spark Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. It is pioneering one-time treatments targeting inherited retinal disorders, hemophilia, and neurodegenerative conditions using proprietary AAV vector technology. It is a subsidiary of Roche.
Address: 3737 Market Street, Suite 1300, Philadelphia, PA 19104
Phone: 1‑855‑SPARKTX (855) 772‑7589 or (215) 220-9300
-
Greater Philadelphia Area Ranks Among Top 10 U.S. Biopharma Clusters
The Greater Philadelphia area earned high marks for its efforts to attract life sciences companies, writes Alex Philippidis for Genetic…
-
Here’s How Pennsylvania Can Unlock Its Potential to Become a True Economic Leader
Pennsylvania companies are changing the world. It’s on us to support them and their workers and create opportunities for more…
-
Former CEO Shares Thoughts on How Gov. Shapiro Can Boost State’s Innovation Economy
Jeff Marrazzo, the former CEO of Philadelphia-based Spark Therapeutics and a member of the innovation subcommittee of Gov. Josh Shapiro’s…
-
Bryn Mawr’s John Furey Stays “Hands-On,” Bio-Tech Firm Triples in Size
It seemed the right thing for John Furey to do—take 20 years of experience in different pharma roles, including as…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
